期刊文献+

父系表达基因10蛋白在肝细胞癌组织中的表达及临床意义 被引量:4

Expression of PEG10 in human hepatocellular carcinoma and its clinical significance
下载PDF
导出
摘要 目的研究父系表达基因10(PEG10)在肝细胞癌中的表达及其临床意义。方法收集2006年3月至2011年5月52例肝细胞癌组织,采用免疫组织化学法检测组织中PEG10表达,分别以31例癌旁组织、10例正常肝组织标本和10例胎盘组织作为对照。回顾52例肝细胞癌患者各项指标检测结果,并分析各项指标与PEG10表达的关系。结果 PEG10在肝细胞癌组织中阳性表达率为90.38%(47/52),显著高于癌旁正常组织[67.74%(21/31)]和正常肝组织(0),差异有统计学意义(P<0.01)。PEG10表达的阳性程度与肝细胞的分化程度呈正相关(r=0.441,P<0.01)。PEG10表达在肿瘤大小、不同年龄和性别患者间比较,差异无统计学意义(P>0.05)。结论 PEG10在肝细胞癌组织中表达的阳性程度与肿瘤分化程度有关,对肝细胞癌的敏感性好,但其特异性不强。 Objective To investigate the expression of PEG10 as HCC cell marker in human hepatocellular carcinoma tissues and its clinical significance. Methods From March 2006 to May 2011,52 paraffin samples of human hepatocellular carcinoma tissues were obtained, and the expression of PEG10 was examined by immunohistochemical staining. Another 31 normal tissues adjacent to human hepatocellular carcinoma and 10 normal liver tissues and 10 normal placenta tissues were served as controls. The clinicopathological data of 52 patients with hepatocellular carcinoma were retrospectively analyzed, and their relationship with the expression of PEG10 was analyzed. Results The positive expression rate of PEG10 in human hepatocellular carcinoma tissues was 90.38% (47/52), which was significantly higher than that in normal tissues adjacent to human hepatocellular carcinoma(67. 74%,21/31) and nor mal liver tissues(0)(P〈0.01). The expression of PEG10 was positively correlated with the different differentiation of hepatocellular carcinoma(r= 0. 441,P〈0.01). There was no significant difference in the expression of PEG10 a mong patients with the different differentiation of tumor size age and gender(P〉0.05). Conclusion The expression of PEG10 is correlated with the pathology' stage. The sensitivity of hepatocellular carcinoma is good, but its specificity is not strong.
出处 《检验医学与临床》 CAS 2011年第24期2951-2953,共3页 Laboratory Medicine and Clinic
基金 上海市宝山区科委基金资助项目(08-E-26)
关键词 父系表达基因10 病理分级 肝细胞癌 PEG10 pathology stage hepatocellular carcinoma
  • 相关文献

参考文献17

二级参考文献22

共引文献279

同被引文献24

  • 1吴晓旻,熊洁.PEG10基因的克隆、原核表达及多克隆抗体的制备[J].免疫学杂志,2009,25(4):488-489. 被引量:1
  • 2Shi-Ting Bao, Shui-Qing Gui and Mu-Sheng Lin Department of Hepatobiliary Surgery, Affiliated Hospital of Guangdong Medical College, Zhanjiang 524001, China.Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma[J].Hepatobiliary & Pancreatic Diseases International,2006,5(4):580-583. 被引量:28
  • 3常莹,陶璐薇,陈孝平,周秀敏,宋宇虎,黄锦,张琼,林菊生.肝癌组织中遗传印记基因PEG10表达的特异性及其意义[J].世界华人消化杂志,2005,13(12):1408-1411. 被引量:27
  • 4隋峰,毛羽.生长激素受体与胰岛素样生长因子Ⅱ受体在肝细胞性肝癌中的表达[J].临床和实验医学杂志,2007,6(5):35-37. 被引量:12
  • 5Soresi M, Magliarisi C, Campagna P, et al. Usefulness of alpha- fetoprotein in the diagnosis of hepatocellular carcinoma [ J ]. Anticancer Res, 2003, 23(2C) : 1747 - 1753.
  • 6Ono R, Kobayashi S, Wagatsuma H, et al. A retrotransposon- derived gene, PEG10, is a novel imp rinted gene located on human chromosome 7q21 [ J]. Genomics, 2001,73 (2) : 232 - 237.
  • 7Dong H, Zhang H, Liang J, et al. Digital karyotyping reveals probable target genes at 7q21.3 locus in hepatocellular carcinoma[J/OA~. BMC Med Genomics, 2011,4(111): 60.
  • 8Ip WK, Lai PB, Wong NL, et al. Identification of PEG10 as a progression related biomarker for hepatocellular carcinoma [ J ]. Cancer Letters, 2007, 250(2) : 284 -291.
  • 9Xiong J, Qin J, Zheng Y, et al. PEG10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metallopmteinase-2 and -9[J]. Clin Invest Med, 2012, 35 (3): 117-125.
  • 10Tsuji K, Yasui K, Gen Y, et al. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma [ J ]. Cancer Genet Cytogenet, 2010, 198(2) : 118 -125.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部